Back to top
more

IPC THE HOSPITL (IPCM)

(Delayed Data from NSDQ)

$80.17 USD

80.17
559,044

+0.01 (0.01%)

Updated Nov 20, 2015 03:59 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[IPCM]

Reports for Purchase

Showing records 1 - 20 ( 111 total )

Industry: Medical Services

Record: 1

11/23/2015

Company Report

Pages: 4

Terminating Coverage

Provider: KEYBANC CAPITAL MARKETS

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 2

10/27/2015

Company Report

Pages: 8

Disappointing 3Q on Lower Productivity; Not Expected to Impact Offer by TMH

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 3

08/10/2015

Company Report

Pages: 4

Downgrade to Sector Weight Post- Acquisition

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 4

08/10/2015

Daily Note

Pages: 16

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 5

07/29/2015

Company Report

Pages: 8

LT Thesis Remains Intact Despite Slight Miss

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 6

07/20/2015

Daily Note

Pages: 14

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 7

07/19/2015

Industry Report

Pages: 7

Healthcare Facilities and Services: Hip and Knee Bundle a Positive for Physician Management Companies

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 8

06/25/2015

Industry Report

Pages: 6

Healthcare Facilities -SCOTUS Overhang Lifted

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 9

04/29/2015

Company Report

Pages: 7

LT Story Still Intact Despite Soft 1Q EPS

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 10

04/13/2015

Daily Note

Pages: 13

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Industry: Medical Services

Record: 11

04/13/2015

Company Report

Pages: 11

Raising Estimates; Upgrading to Overweight

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 12

02/19/2015

Company Report

Pages: 7

Reducing Estimates on Larger than Expected Payment Headwinds

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 13

10/23/2014

Company Report

Pages: 7

Reducing Estimates on Attrition Uptick; Guidance Lowered

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 14

07/25/2014

Company Report

Pages: 7

Solid Q2 Reported. Company Affirmed Guidance. We Are Increasing Our Forecast Given Improved Visibility. Maintain Buy Rating And 55 PT

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 15

07/24/2014

Company Report

Pages: 8

Growth Recovers from 1Q, but Trimming Estimates Slightly

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 16

05/15/2014

Daily Note

Pages: 3

Discontinuation of Research Coverage

Provider: FELTL & COMPANY

Price: 10.00

Research Provided by a Third Party

Industry: Medical Services

Record: 17

04/24/2014

Company Report

Pages: 7

1Q14 underperformed expectations; guidance now appears optimistic

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 18

04/24/2014

Company Report

Pages: 8

Weak Q1 Reported. Company Affirm Guidance. We Are Reducing Our Forecast Given Limited Visibility At This Point. Maintain Buy Rating But Reduce PT From $70 To $55

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 19

04/23/2014

Company Report

Pages: 7

Steep Ramp to Achieve Reaffirmed Guidance After a Tough 1Q

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Industry: Medical Services

Record: 20

02/21/2014

Company Report

Pages: 7

4Q13 rev inline yet higher G&A clips EPS and 2014 guidance

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party
// eof